At 6-h post-treatment (primary endpoint), the placebo-adjusted LS mean change from baseline was − 0.323 l; however, it did not reach statistical significance at the 5% level.
← all excerpts
Efficacy of Nebulized Glycopyrrolate on Lung Hyperinflation in Patients with COPD.
1
—
—